Erlotinib-Induced Papulopustular Eruption and Mucositis
Erlotinib is an epidermal growth factor inhibitor that is used in the treatment of advanced stage cancers. Cutaneous reactions to erlotinib use have been observed. A 70-year-old male patient presented with the complaint of a rash on his nose and a lesion in the mouth. The patient history included a...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
KARE Publishing
2018-07-01
|
| Series: | Southern Clinics of Istanbul Eurasia |
| Subjects: | |
| Online Access: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=scie&un=SCIE-83803 |